[P56] Poster Session 56　Gastrointestinal Cancer（Colorectal Cancer 2）

[P56-7] The Safety and feasibillity for biweekly trifluridine/tipiracil plus bevacizumab regimen in advanced colorectal cancer

^○Hirotaka Inoue^1,2, Ken Kondo³, Koyama Ichiko⁶, Eri Wakita⁵, Yoko Nakamura⁵, Shiori Amano², Kazuhiro Shiraishi⁴, Keiji Sugiyama⁴, Chiyoe Kitagawa⁴, Masato Kataoka³, Shin Takeda³ (1.Department of Clinical Research Planning and Management, Nagoya Medical Center Clinical Research Center, 2.Department of Pharmacy, National Hospital Organization Nagoya Medical Center, 3.Department of Surgery, National Hospital Organization Nagoya Medical Center, 4.Department of Medical Oncology, National Hospital Organization Nagoya Medical Center, 5.Department of Pharmacy, National Hospital Organization Toyohashi Medical Center, 6.Department of Pharmacy, National Hospital Organization Mie Central Medical Center)